Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?

Neurology. 1999 Oct 22;53(7):1380-1. doi: 10.1212/wnl.53.7.1380.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Humans
  • Interferon-beta / therapeutic use
  • Matrix Metalloproteinase 2 / metabolism*
  • Matrix Metalloproteinase 9 / metabolism*
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / enzymology*
  • Multiple Sclerosis / metabolism
  • Tissue Inhibitor of Metalloproteinases / metabolism

Substances

  • Adjuvants, Immunologic
  • Tissue Inhibitor of Metalloproteinases
  • Interferon-beta
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9